EUVIMEDEUVIMED entdecken
Crossref

Cardiac adverse events associated with axitinib: A real-world pharmacovigilance study based on the Japanese adverse drug event report database

Keiko Hosohata, Risa Morioka, Riku Nakamoto, Yuko Kanbayashi

Supportive Care in Cancer · 2026-05 · 34 (5)

DOI: 10.1007/s00520-026-10642-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, online erschienen am 24.04.2026. Verfasst von Keiko Hosohata und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Evaluation and Informatics, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, 7-2-1 Kami-Ohno, Himeji, Hyogo, 670-8524…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Axitinib, Heart Diseases, Protein Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the disproportionality, times to onset, and outcomes of cardiac adverse events (AEs) associated with axitinib, using data from the Japanese Adverse Drug Event Report (JADER) database. METHODS: We analyzed data for the period from April 2004 to December 2024. Those on cardiac AEs were extracted and the disproportionality of axitinib-associated AEs was assessed by calculating reporting odds ratios (RORs). RESULTS: Of the 2,988,681 reports with sex and age information, we identified 4788 reports of AEs associated with axitinib, including 508 cardiac AEs. Signals were detected for 16 cardiac AEs after adjustment for sex and age. Fatal outcomes were reported for five of these events with particularly high rates observed for cardiac failure, myocarditis, and immune-mediated myocarditis. Median times to onset indicated that cardiac AEs associated with axitinib occurred 14 to 420 days after administration. Weibull distributions showed that seven AEs (blood pressure increased, myocardial infarction, acute myocardial infarction, blood pressure systolic increased, oedema peripheral, oedema, and generalised oedema) occurred constantly throughout the exposure period (random failure type), and stress cardiomyopathy and immune-mediated myocarditis developed in a dose-dependent manner (wear-out failure-type). CONCLUSIONS: We focused on cardiac AEs associated with axitinib as post-marketing AEs. Some with fatal outcomes may occur not only early in treatment but also later in the course. Continuous monitoring is essential to ensure timely detection and management of these potentially serious AEs in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsAxitinibHeart DiseasesProtein Kinase InhibitorsAdolescentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedYoung AdultAdverse Drug Reaction Reporting SystemsDatabases, FactualJapanPharmacovigilanceTime Factors

Stichwörter der Autor:innen

AxitinibCardio-oncologyJapanese adverse drug event report databaseOutcomeTime to onset

Substanzen

Antineoplastic AgentsAxitinibProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Drug Evaluation and Informatics, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, 7-2-1 Kami-Ohno, Himeji, Hyogo, 670-8524, Japan. hosohata@gm.himeji-du.ac.jp.
  • Department of Drug Evaluation and Informatics, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, 7-2-1 Kami-Ohno, Himeji, Hyogo, 670-8524, Japan.
  • Department of Evaluation for Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, 7-2-1 Kami-Ohno, Himeji, Hyogo, 670-8524, Japan.

Zitieren

APA

Hosohata, K., Morioka, R., Nakamoto, R., & Kanbayashi, Y. (2026). Cardiac adverse events associated with axitinib: A real-world pharmacovigilance study based on the Japanese adverse drug event report database. Supportive Care in Cancer, 34(5). https://doi.org/10.1007/s00520-026-10642-w

Vancouver

Hosohata K, Morioka R, Nakamoto R, Kanbayashi Y. Cardiac adverse events associated with axitinib: A real-world pharmacovigilance study based on the Japanese adverse drug event report database. Supportive Care in Cancer. 2026;34(5). doi:10.1007/s00520-026-10642-w

BibTeX
@article{Hosohata2026,
  author = {Hosohata, Keiko and Morioka, Risa and Nakamoto, Riku and Kanbayashi, Yuko},
  title = {Cardiac adverse events associated with axitinib: A real-world pharmacovigilance study based on the Japanese adverse drug event report database},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {5},
  doi = {10.1007/s00520-026-10642-w}
}
Kostenlos starten →